-
Access to anticancer and orphan medicines through compassionate use programs and named patient basis in seven European countries
Rosenberg, N., Post, H. C., Schutte, T., de Visser, S. J., Bartelink, I., Pasmooij, A. M. G., van Laarhoven, H. W. M. & Hollak, C. E. M., 1 Nov 2025, In: ESMO open. 10, 11, 105855.Research output: Contribution to journal › Article › Academic › peer-review
-
Access to EU-Authorized Nonreimbursed Anticancer Medicines: An Explorative Survey Among Dutch Medical Oncologists
Post, H. C., Bomhof, C. H. C., Schermer, M., Hollak, C. E. M., van Laarhoven, H. W. M., Schutte, T. & Bunnik, E. M., Oct 2025, In: Clinical Therapeutics. 47, 10, p. 894-903 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Improving the usability of grading scales for drug-induced ototoxicity with a focus on real world data collection
Koot, M., Crul, M., van Balen, D. & Schutte, T., Jun 2025, In: European Archives of Oto-Rhino-Laryngology. 282, 6, p. 3343-3347 5 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
